Brooklyn Stock Buy Hold or Sell Recommendation

BTX
 Stock
  

USD 0.54  0.02  3.85%   

Considering the 90-day investment horizon and your complete indifference towards market risk, our recommendation regarding Brooklyn Immunotherapeutics is 'Strong Buy'. Macroaxis provides Brooklyn Immunotherapeuti buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BTX positions. The advice algorithm takes into account all of Brooklyn Immunotherapeuti's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Brooklyn Immunotherapeuti's buy-and-hold perspective. Continue to Brooklyn Immunotherapeuti Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Brooklyn and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Brooklyn Immunotherapeutics.

Execute Brooklyn Immunotherapeuti Buy or Sell Advice

The Brooklyn recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Brooklyn Immunotherapeutics. Macroaxis does not own or have any residual interests in Brooklyn Immunotherapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Brooklyn Immunotherapeuti's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Brooklyn ImmunotherapeutiBuy Brooklyn Immunotherapeuti
Strong Buy

Volatility

RiskyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds of Distress

LowDetails

Economic Sensitivity

Actively responds to the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Brooklyn Immunotherapeutics has a Risk Adjusted Performance of (0.44), Jensen Alpha of (1.49), Total Risk Alpha of (1.07) and Treynor Ratio of (0.97)
We provide trade advice to complement the prevailing expert consensus on Brooklyn Immunotherapeuti. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Brooklyn Immunotherapeuti is not overpriced, please confirm all Brooklyn Immunotherapeuti fundamentals, including its gross profit and the relationship between the debt to equity and working capital . As Brooklyn Immunotherapeuti appears to be a penny stock we also recommend to validate its price to book numbers.

Brooklyn Immunotherapeuti Trading Alerts and Improvement Suggestions

Brooklyn Immunotherapeuti generated a negative expected return over the last 90 days
Brooklyn Immunotherapeuti has high historical volatility and very poor performance
Brooklyn Immunotherapeuti has some characteristics of a very speculative penny stock
Brooklyn Immunotherapeutics was previously known as BROOKLYN IMMUNOTHERAPEUTICS INC and was traded on NYSEMKT Exchange under the symbol NTN.
The company reported the last year's revenue of 3.45 M. Reported Net Loss for the year was (122.32 M) with profit before taxes, overhead, and interest of 4.69 M.
Brooklyn Immunotherapeutics has about 16.98 M in cash with (23.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3.
Brooklyn Immunotherapeuti has a poor financial position based on the latest SEC disclosures
Roughly 42.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Exercise or conversion by Damour Kevin of 17573 shares of Brooklyn Immunotherapeuti subject to Rule 16b-3

Brooklyn Immunotherapeuti current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Brooklyn analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Brooklyn analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price4.50
Target Median Price4.50
Target High Price5.00
Recommendation Mean2.00
Number Of Analyst Opinions2
Target Low Price4.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Brooklyn Immunotherapeuti Returns Distribution Density

The distribution of Brooklyn Immunotherapeuti's historical returns is an attempt to chart the future uncertainty of Brooklyn Immunotherapeuti's future price movements. The chart of the probability distribution of Brooklyn Immunotherapeuti stock daily returns describes the distribution of returns around its average expected value. We use Brooklyn Immunotherapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Brooklyn Immunotherapeuti returns is essential to provide solid investment advice for Brooklyn Immunotherapeuti stock.
Mean Return-1.85Value At Risk-10.71
Potential Upside8.33Standard Deviation5.85
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Brooklyn Immunotherapeuti historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Brooklyn Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Brooklyn Immunotherapeuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brooklyn Immunotherapeutics backward and forwards among themselves. Brooklyn Immunotherapeuti's institutional investor refers to the entity that pools money to purchase Brooklyn Immunotherapeuti's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Armistice Capital LlcCommon Shares5.5 M11.3 M
Blackrock IncCommon Shares2.4 M4.9 M
Cypress Point Wealth Management LlcCommon Shares1.9 M3.9 M
Naviter Wealth LlcCommon Shares1.6 M3.2 M
Vanguard Group IncCommon Shares1.3 M2.6 M
Inverness Counsel LlcCommon Shares1.2 M2.5 M
Jpmorgan Chase CoCommon Shares822.2 K1.7 M
Citadel Advisors LlcCall Options108.7 K223 K
Note, although Brooklyn Immunotherapeuti's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Brooklyn Immunotherapeuti Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(1.45 M)(1.58 M)(1.09 M)(39 K)(154 K)(166.16 K)
Depreciation Amortization and Accretion2.32 M2.76 M3.17 M98 K459 K471.08 K
Net Cash Flow or Change in Cash and Cash Equivalents(2.37 M)(592 K)623 K(3.47 M)15.36 M16.57 M
Issuance Repayment of Debt Securities(3.14 M)(1.62 M)(1.04 M)310 K(942 K)(966.79 K)
Net Cash Flow from Financing(1.47 M)(303 K)(1.1 M)4.67 M61.59 M66.45 M
Net Cash Flow from Investing(1.45 M)(1.58 M)(1.06 M)(39 K)(22.74 M)(23.34 M)
Net Cash Flow from Operations549 K1.36 M2.74 M(8.1 M)(23.49 M)(24.11 M)
Effect of Exchange Rate Changes on Cash24 K63 K(75 K)42 K48.3 K52.11 K
Share Based Compensation457 K443 K206 K91 K5.24 M5.65 M

Brooklyn Immunotherapeuti Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Brooklyn Immunotherapeuti or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Brooklyn Immunotherapeuti stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Brooklyn stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-1.49
β
Beta against DOW1.91
σ
Overall volatility
6.01
Ir
Information ratio -0.29

Brooklyn Immunotherapeuti Volatility Alert

Brooklyn Immunotherapeutics exhibits very low volatility with skewness of 0.23 and kurtosis of 1.56. However, we advise investors to further study Brooklyn Immunotherapeutics technical indicators to make sure all market info is available and is reliable. Brooklyn Immunotherapeutics is a potential penny stock. Although Brooklyn Immunotherapeuti may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Brooklyn Immunotherapeutics. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Brooklyn instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Brooklyn Immunotherapeuti Fundamentals Vs Peers

Comparing Brooklyn Immunotherapeuti's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Brooklyn Immunotherapeuti's direct or indirect competition across all of the common fundamentals between Brooklyn Immunotherapeuti and the related equities. This way, we can detect undervalued stocks with similar characteristics as Brooklyn Immunotherapeuti or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Brooklyn Immunotherapeuti's fundamental indicators could also be used in its relative valuation, which is a method of valuing Brooklyn Immunotherapeuti by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Brooklyn Immunotherapeuti to competition
FundamentalsBrooklyn ImmunotherapeutiPeer Average
Return On Equity(0.0012) %(0.31) %
Return On Asset(74.20) %(0.14) %
Current Valuation46.06 M16.62 B
Shares Outstanding52.04 M571.82 M
Shares Owned by Insiders41.76 %10.09 %
Shares Owned by Institutions23.41 %39.21 %
Number of Shares Shorted2.79 M4.71 M
Price to Earning3.97 X28.72 X
Price to Book2.19 X9.51 X
Price to Sales39.92 X11.42 X
Revenue3.45 M9.43 B
Gross Profit4.69 M27.38 B
EBITDA(27.31 M)3.9 B
Net Income(122.32 M)570.98 M
Cash and Equivalents16.98 M2.7 B
Cash per Share0.30 X5.01 X
Total Debt2.72 M5.32 B
Debt to Equity0.42 %48.70 %
Current Ratio5.10 X2.16 X
Book Value Per Share0.25 X1.93 K
Cash Flow from Operations(23.49 M)971.22 M
Short Ratio6.17 X4.00 X
Earnings Per Share(0.45) X3.12 X
Price to Earnings To Growth(0.08) X4.89 X
Number of Employees1018.84 K
Beta3.15-0.15
Market Capitalization28.6 M19.03 B
Total Asset94.66 M29.47 B
Retained Earnings(241.87 M)9.33 B
Working Capital34.77 M1.48 B
Current Asset47.24 M9.34 B
Current Liabilities12.46 M7.9 B
Z Score3.28.72
   Exercise or conversion by Damour Kevin of 17573 shares of Brooklyn Immunotherapeuti subject to Rule 16b-3 [view details]

Brooklyn Immunotherapeuti Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Brooklyn . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution56894.74
Daily Balance Of Power0.3333
Rate Of Daily Change1.04
Day Median Price0.54
Day Typical Price0.54
Price Action Indicator0.01

About Brooklyn Immunotherapeuti Buy or Sell Advice

When is the right time to buy or sell Brooklyn Immunotherapeutics? Buying financial instruments such as Brooklyn Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Brooklyn Immunotherapeuti investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Receivables4.6 K4.72 K
Inventories900923.68

Use Investing Ideas to Build Portfolios

In addition to having Brooklyn Immunotherapeuti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banks Thematic Idea Now

Banks
Banks Theme
Large and small money and credit banks and credit services. The Banks theme has 30 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
View All  Next Launch Banks
Continue to Brooklyn Immunotherapeuti Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Brooklyn Immunotherapeuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brooklyn Immunotherapeuti. If investors know Brooklyn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brooklyn Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
30.9 M
Return On Assets
-0.68
Return On Equity
-17.56
The market value of Brooklyn Immunotherapeuti is measured differently than its book value, which is the value of Brooklyn that is recorded on the company's balance sheet. Investors also form their own opinion of Brooklyn Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Brooklyn Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brooklyn Immunotherapeuti's market value can be influenced by many factors that don't directly affect Brooklyn Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brooklyn Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Brooklyn Immunotherapeuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brooklyn Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.